Virus News and Research

Latest Virus News and Research

Department of Health to conduct statewide clinics to administer free H1N1 vaccine

The Department of Health today announced it will conduct statewide clinics from Nov. 20-22 to administer free H1N1 vaccine to individuals in the recommended target groups that have not had previous access to the vaccine.

16 Nov 2009

NIDA awards $17 million to University of California to establish TMARC

Igor Grant, MD, professor of psychiatry at the University of California, San Diego School of Medicine, and colleagues have been awarded a $17 million grant from the National Institute on Drug Abuse to establish the Translational Methamphetamine AIDS Research Center (TMARC) at UC San Diego. Grant is director of the HIV Neurobehavioral Research Center (HNRC), a clinical research center designated and funded by the National Institute of Mental Health.

16 Nov 2009

WHO revises clinical H1N1 guidelines, sends antivirals to some hard-hit nations

On Thursday, the WHO issued revised guidance for the clinical management of H1N1 (swine) flu, the Associated Press reports. According to the AP, the WHO "says doctors shouldn't wait for lab confirmation before giving anti-viral drugs to pregnant women and other at-risk groups with suspected swine flu" (11/12).

16 Nov 2009

CDC releases revised H1N1 estimates

USA Today: As expected, CDC released revised H1N1 estimates Thursday indicating that 3,900 people in the U.S. have died from the infection, including 540 children (Sternberg, 11/12).

13 Nov 2009

CaringBridge, a solution to keep patients from feeling isolated during hospital stays

Hospitals are placing higher restrictions on their visitation policies due to the threat of H1N1. While this helps reduce exposure to the virus, it also means that patients will see less of their family and friends, increasing their feeling of isolation.

13 Nov 2009

Scientists describe how HIV assemble at the membrane of infected cells and are released to attack healthy cells

Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Much has been learned about HIV-1, the virus that causes the disease.

13 Nov 2009

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

The U.S. Food and Drug Administration has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

13 Nov 2009

New findings on human genome may be useful for developing specific AIDS drugs

The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

CDC expected to revise estimated number of U.S. H1N1 deaths

Ahead of the anticipated CDC release of revised U.S. H1N1 (swine flu) death toll estimates, Reuters examines how the agency and WHO measure the impact of the virus, after both organizations "stopped trying to count actual cases months ago, once it became clear that H1N1 was a pandemic that would infect millions."

12 Nov 2009

Tips for preventing cancer

The risk of cancer can be dramatically reduced through everyday choices about diet, exercise and tobacco use, according to a Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource.

12 Nov 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Net sales for the fourth quarter of fiscal 2009 were $42,461,000 as compared to $36,475,000 for the same period of the prior fiscal year, an increase of 16%. Net earnings for the fourth quarter of fiscal 2009 were $8,930,000, or $ 0.22 per diluted share, up 16% over the fourth quarter of fiscal 2008.

12 Nov 2009

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Amarillo Biosciences, Inc. reported that the American Veterinary Medical Association (AVMA) recently confirmed that a household cat in Iowa developed signs of respiratory infection caused by H1N1 influenza virus.

12 Nov 2009

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

CSL Biotherapies, a subsidiary of CSL Limited, one of the world’s leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application for accelerated approval of its seasonal flu vaccine, Afluria® (Influenza Virus Vaccine) for use in the pediatric population aged 6 months and older.

12 Nov 2009

Oregon state officials confirm that three more ferrets have tested positive for the 2009 H1N1 virus

Three more ferrets in Oregon have tested positive for the 2009 pandemic influenza H1N1 virus, state officials confirmed this afternoon, bringing the total number of cases affecting ferrets in the state to four.

12 Nov 2009

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

Emergency Management & Safety Solutions (EMS Solutions), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help companies better prepare for and prevent transmission of this year's H1N1 flu pandemic. Today, over 180 countries have experienced the H1N1 virus outbreak and approximately 6,500 people have died -- including over 1,500 in North America, according to the European Center for Disease Prevention and Control.

12 Nov 2009

New website on healthy lifestyle and its issues launched by Healthy Life Network

HealthyLifeNetwork.com is officially online and making its healthful presence known on the world-wide web. The new site has been in development for sometime but overall the time to market from concept to publish was fast-tracked by a Chicago-based team of writers, editors, designers and marketing wizards.

12 Nov 2009

UK research funders announce support for a series of H1N1 2009 research projects

Leading UK research funders today announce -7.5 million of funding for a series of projects aimed at understanding the development and spread of pandemic influenza H1N1 2009 - or 'swine flu'. The research will look at every aspect of the virus, on pig farms, in pig and human populations, and in hospital intensive care units.

11 Nov 2009

First draft of the cassava genome complete

A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.

11 Nov 2009

Virus News and Research

Latest Virus News and Research

Department of Health to conduct statewide clinics to administer free H1N1 vaccine

NIDA awards $17 million to University of California to establish TMARC

WHO revises clinical H1N1 guidelines, sends antivirals to some hard-hit nations

CDC releases revised H1N1 estimates

CaringBridge, a solution to keep patients from feeling isolated during hospital stays

Scientists describe how HIV assemble at the membrane of infected cells and are released to attack healthy cells

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

New findings on human genome may be useful for developing specific AIDS drugs

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

CDC expected to revise estimated number of U.S. H1N1 deaths

Tips for preventing cancer

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children

Oregon state officials confirm that three more ferrets have tested positive for the 2009 H1N1 virus

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

New website on healthy lifestyle and its issues launched by Healthy Life Network

UK research funders announce support for a series of H1N1 2009 research projects

First draft of the cassava genome complete

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in